Skip to main content
    8

    89bio Inc (ETNB)

    BIOTECHNOLOGY

    $14.84
    +0.00 (+0.00%)

    Last updated: Oct 30, 2025 at 5:00 PM ET

    Earnings

    Performance (10Y)

    Beat Rate
    40%(10/25)
    Avg Surprise
    -108.39%
    Streak
    1 Q
    PeriodReportedEst.SurpriseB/MYoY
    Sep 25
    Reported Nov 6
    		$0.00N/A+100.00%Beat+100.0%
    Jun 25
    Reported Aug 7
    		$-0.71$-0.50-42.00%Miss-47.9%
    Mar 25
    Reported May 1
    		$-0.49$-0.57+13.29%Beat+9.3%
    Dec 24
    Reported Feb 27
    		$-1.02$-0.76-34.32%Miss-104.0%
    Sep 24
    Reported Nov 7
    		$-1.39$-0.64-117.19%Miss-208.9%
    Jun 24
    Reported Aug 5
    		$-0.48$-0.57+15.79%Beat+7.7%
    Mar 24
    Reported May 9
    		$-0.54$-0.46-17.39%Miss+0.0%
    Dec 23
    Reported Feb 29
    		$-0.50$-0.49-2.04%Miss-4.2%
    Sep 23
    Reported Nov 8
    		$-0.45$-0.53+15.09%Beat+21.1%
    Jun 23
    Reported Aug 9
    		$-0.52$-0.41-26.83%Miss+57.7%
    Mar 23
    Reported May 4
    		$-0.54$-0.52-3.85%Miss+57.1%
    Dec 22
    Reported Mar 10
    		$-0.48$-0.69+30.43%Beat+63.1%
    Sep 22
    Reported Nov 10
    		$-0.57$-0.80+28.75%Beat+59.6%
    Jun 22
    Reported Aug 11
    		$-1.23$-1.05-17.14%Miss-19.4%
    Mar 22
    Reported May 11
    		$-1.26$-1.29+2.33%Beat-70.3%
    Dec 21
    Reported Mar 24
    		$-1.30$-1.31+0.76%Beat-106.3%
    Sep 21
    Reported Nov 11
    		$-1.41$-1.06-33.02%Miss-64.0%
    Jun 21
    Reported Aug 12
    		$-1.03$-0.84-22.62%Miss-21.2%
    Mar 21
    Reported May 12
    		$-0.74$-0.69-7.25%Miss+2.6%
    Dec 20
    Reported Mar 24
    		$-0.63$-0.87+27.59%Beat+75.6%
    Sep 20
    Reported Nov 10
    		$-0.86$-0.84-2.38%Miss+97.2%
    Jun 20
    Reported Aug 13
    		$-0.85$-0.83-2.41%Miss-
    Mar 20
    Reported May 13
    		$-0.76$-0.86+11.63%Beat-
    Dec 19
    Reported Mar 18
    		$-2.58$-0.94-174.47%Miss-
    Sep 19
    Reported Dec 18
    		$-30.63$-1.20-2452.50%Miss-

    Key Metrics

    Valuation
    P/E RatioN/AEV/EBITDAN/A
    Price/FCFN/AFCF YieldN/A
    Profitability
    Profit MarginN/AOperating MarginN/A
    ROEN/AROICN/A
    Financial Health
    Debt/EquityN/AInterest CoverageN/A
    Current RatioN/AQuick RatioN/A
    Trading Statistics
    BetaN/AAvg VolumeN/A
    52-Week HighN/A52-Week LowN/A

    Technical Indicators Dashboard

    Moving Averages

    SMA 10$14.81
    SMA 20$14.81
    SMA 50$12.52
    SMA 200N/A
    EMA 10$14.81
    EMA 20$14.53
    EMA 50$13.14
    EMA 200$9.86

    MACD

    Line: 0.53Signal: 0.70Hist: -0.17

    ADX

    ADX: 55.6+DI: 45.0-DI: 11.6

    Aroon & PSAR

    Aroon Up20.0
    Aroon Down12.0
    PSAR$11.12

    Bollinger Bands

    Upper Band$14.88
    Lower Band$14.75
    %B Position82%(Upper)
    Band Width0.71

    RSI (14-Day)

    Overbought
    76.9

    Momentum Oscillators

    Stoch %K73.5
    Stoch %D64.9
    Williams %R-23.1
    ROC (10d)0.5%
    Momentum0.07
    CCI (20d)64.8
    MFI (14d)85.7

    Volatility Measures

    ATR (14d)$0.15(1.0%)
    StdDev (20d)0.03
    Hist Vol3.1%(Low)

    Volume Flow

    VWAP$14.84
    OBV72.5M
    AD Line-104.5M
    CMF (20d)-0.132

    Volume Metrics

    Avg Vol (20d)5.9M
    Vol RatioN/A
    VWMA (20d)$14.83

    Pivot Points

    R3$14.92
    R2$14.89
    R1$14.87
    Pivot Point$14.84
    S1$14.82
    S2$14.79
    S3$14.77

    Advanced Oscillators

    TSI54.99
    Ultimate Osc40.5
    KST269.83

    Financial Data

    QuarterJun 2025Mar 2025Dec 2024Sep 2024Jun 2024Mar 2024Dec 2023Sep 2023Jun 2023Mar 2023Dec 2022Sep 2022
    Total Revenue$0$0$21,000$0$0$0$234,000$0$0$0$0$0
    Cost of Revenue$0$0$21,000$0$0$0$16,000$0$0$0$55,000$0
    Gross Profit$0$0$21,000$0$0$0$-16,000$0$0$0$-55,000$0
    Operating Expenses$115.82M$75.91M$122.00M$151.94M$53.44M$57.28M$41.21M$39.34M$42.13M$28.52M$25.36M$27.04M
    R&D$103.90M$64.39M$111.30M$141.44M$44.87M$47.43M$33.59M$31.42M$34.91M$22.31M$19.06M$22.20M
    SG&A$11.92M$11.52M$10.70M$10.50M$8.57M$9.85M$7.61M$7.93M$7.21M$6.22M$6.30M$4.84M
    Operating Income$-115,824,000$-75,909,000$-122,005,000$-151,938,000$-53,436,000$-57,277,000$-41,206,000$-39,345,000$-42,129,000$-28,524,000$-25,362,000$-27,041,000
    Interest Income$0$0$0$0$0$0$0$0$0$0$0$0
    Interest Expense$1.14M$1.27M$1.19M$2.36M$874,000$863,000$866,000$959,000$894,000$2.08M$545,000$535,000
    Income Before Tax$-110,751,000$-71,138,000$-118,097,000$-148,869,000$-47,837,000$-51,584,000$-36,368,000$-34,725,000$-38,393,000$-28,836,000$-24,586,000$-26,803,000
    Income Tax Expense$753,000$137,000$257,000$204,000$134,000$97,000$3.87M$0$0$0$16,000$2,000
    Net Income$-111,504,000$-71,275,000$-118,354,000$-149,073,000$-47,971,000$-51,681,000$-40,235,000$-34,725,000$-38,393,000$-28,836,000$-24,602,000$-26,805,000
    EBITDA$-111,614,000$-71,304,000$-118,656,000$-148,805,000$-49,367,000$-53,372,000$-37,252,000$-35,626,000$-38,400,000$-27,568,000$-24,286,000$-26,488,000
    EBIT$-109,614,000$-69,871,000$-116,906,000$-146,507,000$-46,963,000$-50,721,000$-35,502,000$-33,766,000$-37,499,000$-26,761,000$-24,041,000$-26,268,000
    * Some calculated fields are derived from available data when not provided by source

    Related GNG Research

    No research available

    Be the first to write about ETNB

    News

    No news available

    Company news will appear here when available

    ETNB Competitors

    CompanyTicker
    HUTCHMED DRCHCM
    Supernus Pharmaceuticals IncSUPN
    MBX Biosciences, Inc. Common StockMBX
    Prestige Brand Holdings IncPBH
    Maravai Lifesciences Holdings IncMRVI
    UFP Technologies IncUFPT
    Beam Therapeutics IncBEAM
    Day One Biopharmaceuticals IncDAWN

    Sector: Healthcare

    ETNB Bull Case vs Bear Case

    Bear case

    • ETNB beat EPS estimates in 37.5% of its last 8 reported quarters.

    ETNB Earnings: Beat Rate and Next Report

    Beat rate
    3 of 8 quarters (37.5%)
    Average surprise
    -10.5%

    Frequently Asked Questions About ETNB

    Does ETNB pay dividends?

    89bio Inc (ETNB) does not currently pay a regular dividend.

    Related stocks

    Sector: Healthcare

    All stocks starting with E

    Get full access to GNG Research

    Create a free account to access portfolio tracking, advanced tools, and more.

    Create Free AccountLog In